We use cookies for a better user experience. Read our Privacy Policy

I Agree

Anti-Tumor Drugs Market

Anti-Tumor Drugs Market - Global Industry Analysis, Size, Share, Trends, Growth, and Forecasts, 2021-2031

Anti-Tumor Drugs Market – Overview

The global anti-tumor drugs market is projected to expand at a favorable rate from 2021 to 2031 (forecast period). The number of cancer patients has expanded dramatically, which is expected to drive the anti-tumor drugs market. According to the WHO, global cancer incidence is anticipated to exceed 15 million by 2025, thus increasing the need for anti-tumor and anti-cancer drugs. Furthermore, numerous cancer-related deaths around the world have sparked the interest of governments and non-governmental organizations (NGOs) from various countries. Government investment for R&D on such drugs is projected to boost the anti-tumor drugs market, owing to an increase in demand for a variety of drugs.

Expanding operations in future? To get the perfect launch ask for a custom report

Anti-Tumor Drugs Market – Competitive Landscape

Key players in the global anti-tumor drugs market are Amgen Inc., Astellas Pharma Inc., Bayer AG, Biogen Inc., Celgene Corporation, Eisai Co., Ltd., AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, Otsuka Pharmaceutical Co., Ltd., Novartis International AG, Pfizer Inc., Sanofi S.A., and Teva Pharmaceutical Industries Ltd.

Pharmaceutical firms encounter a variety of product pipelines and seek to capitalize on various phases of the product cycle. Roche, a Swiss pharmaceutical company, has a high market share due to its excellent success rates, improved life-cycle management, and maximal extension of its inline medications. The anticipated growth and size of the market influence companies' decisions to pursue mergers and acquisitions, which leads to the adoption of various product pipelines for future development. Due to significant investments in research and development, companies are building core capabilities in specific drugs. Novartis, another Swiss pharmaceutical company, has a larger pipeline of cancer-related drugs than industry leader Roche and has absorbed GlaxoSmithKline's oncology unit.

Anti-Tumor Drugs Market – Trends and Opportunities

The worldwide anti-tumor drugs market is expected to develop significantly over the forecast period. The market's expansion can be ascribed to rising demand and continuing advancements in the realm of medicine.

Moreover, rising occurrences of various types of cancer, the availability of various therapy choices, impending patents, and advances in the field of medicine are projected to drive anti-tumor drugs market growth. These drugs are used in a variety of healing treatments, including surgery, radiation, chemotherapy, targeted therapy, and immunotherapy. For specific forms of tumors/cancer, various techniques such as stem cell transplant and blood transfusion are used. Immunotherapy and targeted therapy techniques have a high growth potential due to their lack of adverse effects and specialized targeted response.

Due to the R&D involved, targeted therapy, which is largely a chemotherapy approach, may experience a significant market increase. This technique attempts to treat tumors by employing specifically tailored medications that work solely on the specific regions of the body, inflicting little or no damage to the surrounding areas. Targeted therapy includes two types of drugs: small molecule therapeutics and monoclonal antibody. Monoclonal antibody drugs, such as Panitumumab and Rituximab, contain artificial immune system proteins that develop in living cell cultures. The continuing research and technological developments in the field of biotechnology are likely to improve the efficacy and usability of these monoclonal antibody drugs. Moreover, immunotherapy drugs, such as Imatinib, which stimulate the immune system to act against malignant cells, may potentially experience a rise in the worldwide anti-tumor drugs market.

Request a sample to get extensive insights into the Anti-Tumor Drugs Market

Anti-Tumor Drugs Market – Regional Landscape

North America anti-tumor drugs market is projected to experience significant growth during the forecast period. The United States is expected to make a considerable contribution to the regional market.

The anti-tumor drugs market in Asia Pacific is anticipated to expand due to high cancer mortality and a scarcity of effective treatments. Moreover, Chinese and Japanese pharmaceutical companies are projected to provide significant growth prospects to the anti-tumor drugs market in Asia Pacific.

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved